| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Physiology and Biophysics, University of Illinois and University of Illinois College of Medicine Urbana, Illinois 61801
Address requests for reprints to: Dr. Benita S. Katzenellenbogen, Department of Physiology and Biophysics, University of Illinois, 524 Burrill Hall, 407 South Goodwin Avenue; Urbana, Illinois 61801.
Abstract
To investigate the effect of ligand (be it hormone, antihormone, or no hormone) on the interaction between estrogen receptor (ER) and chromatin, we have used formaldehyde as a cross-linking agent in intact MCF-7 human breast cancer cells. After a 1- to 2-h hormone treatment, the cells are exposed for 8 min to formaldehyde, which is added directly to their culture medium to minimize environmental perturbation. Nuclei are prepared from formaldehydetreated cells and their contents are fractionated on CsCI density gradients to separate DNA-protein complexes from free protein. Peak gradient fractions are assayed for the presence of specific proteins by immunoblot of sodium dodecyl sulfate-polyacrylamide gel patterns. Using this approach, we find that 0.15% formaldehyde is optimal for cross-linking ER to chromatin. We detect ER and the large subunit of RNA polymerase II with DNA from formaldehydetreated, but not from untreated cells. On the other hand, actin (a cytoplasmic protein) and small nuclear ribonucleoprotein particle proteins (nuclear RNA binding proteins) are not cross-linked to DNA. Therefore, cross-linking appears to be selective and fractionation is efficient. Interestingly, we detect similar levels of ER (as well as RNA polymerase II) with DNA from formaldehyde-treated cells, regardless of whether the cells are preexposed to estrogen (17β- estradiol at 10–8 M), antiestrogen (ICI 164,384 at 10–7 or 10–6 M), or no hormone. These results, using covalent cross-linking in intact cells, indicate that both ligand-occupied and unoccupied ER are associated with chromatin.
FOOTNOTES
This work was supported by NIH Grants CA-18119 and 5T32-HD-7028. Portions were presented at the 72nd Annual Meeting of The Endocrine Society, Atlanta, GA, June 1990 (Abstract 856).
Received for publication July 2, 1990. Revision received August 22, 1990. Accepted for publication August 22, 1990.
This article has been cited by other articles:
![]() |
P. G. V. Martini, R. Delage-Mourroux, D. M. Kraichely, and B. S. Katzenellenbogen Prothymosin Alpha Selectively Enhances Estrogen Receptor Transcriptional Activity by Interacting with a Repressor of Estrogen Receptor Activity Mol. Cell. Biol., September 1, 2000; 20(17): 6224 - 6232. [Abstract] [Full Text] |
||||
![]() |
C. A. Spencer, M. J. Kruhlak, H. L. Jenkins, X. Sun, and D. P. Bazett-Jones Mitotic Transcription Repression in Vivo in the Absence of Nucleosomal Chromatin Condensation J. Cell Biol., July 10, 2000; 150(1): 13 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. McInerney, K. E. Weis, J. Sun, S. Mosselman, and B. S. Katzenellenbogen Transcription Activation by the Human Estrogen Receptor Subtype {beta} (ER{beta}) Studied with ER{beta} and ER{alpha} Receptor Chimeras Endocrinology, November 1, 1998; 139(11): 4513 - 4522. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ekena, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Determinants of Ligand Specificity of Estrogen Receptor-alpha : Estrogen versus Androgen Discrimination J. Biol. Chem., January 9, 1998; 273(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Dodson and D. J. Shapiro Vigilin, a Ubiquitous Protein with 14 K Homology Domains, Is the Estrogen-inducible Vitellogenin mRNA 3'-Untranslated Region-binding Protein J. Biol. Chem., May 9, 1997; 272(19): 12249 - 12252. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lee and J. Gorski Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy PNAS, December 24, 1996; 93(26): 15180 - 15184. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. McInerney and B. S. Katzenellenbogen Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation J. Biol. Chem., September 27, 1996; 271(39): 24172 - 24178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ekena, K. E. Weis, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Identification of Amino Acids in the Hormone Binding Domain of the Human Estrogen Receptor Important in Estrogen Binding J. Biol. Chem., August 16, 1996; 271(33): 20053 - 20059. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |